HLA Typing for Transplant Industry - Regional Synopsis
North America Market Analysis
The North America HLA typing for transplant market is poised to capture the largest share of 47.5% during the forecast period, 2025-2037. The region benefits from an advanced healthcare infrastructure and a high volume of organ transplant procedures that significantly contribute to the HLA typing. In this regard, the Centers for Disease Control and Prevention states that nearly 90,000 people in the U.S. are affected by sickle cell disease, which reflects the need for accurate HLA matching in treatment procedures. Besides, CMS notified that it expanded reimbursement policies to cover a wide range of HLA typing services, fostering increased access to patients, thereby augmenting industry expansion.
There is a huge opportunity for market in Canada due to its robust medical infrastructure and a growing demand for organ transplants. Besides, there is an exceptional support from the country’s government, due to which Health Canada assigned a significant portion of its federal healthcare budget towards the transplant-associated treatments. Similarly, provincial health ministries in Ontario and Columbia also extended their support with increased investments in HLA typing technologies, aiming to enhance the accuracy. Hence, these factors readily blister the market progression in the region.
APAC Market Statistics
Asia Pacific’s HLA typing for transplant market is anticipated to grow at the fastest rate during the forecast timeline, owing to the increasing medical expenditure, awareness about organ donation, and advancements in molecular diagnostics. The increasing burden of chronic diseases and innovations such as next-generation sequencing and polymerase chain reaction enhance the accuracy and efficiency of HLA typing, resulting in positive patient outcomes. This further led to a projection of the market to reach USD 172.6 million in the next few years, with expanded access to HLA typing across the region.
India’s market is unfolding remarkable growth opportunities, which are expected to reach USD 59.9 million by 2030, rising at a CAGR of 11.8%. Besides, it is noted that the country’s government offers its extended support through the establishment of the DATRI Blood Stem Cell Donors Registry, which led to expanded access to HLA typing services in India. Additionally, this resulted in more than 1,200 successful transplants, highlighting the critical role of HLA compatibility in bringing positive outcomes, further accelerating the adoption of HLA typing in the transplant market by 2037.
